DE69229269T2 - Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik - Google Patents

Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik

Info

Publication number
DE69229269T2
DE69229269T2 DE69229269T DE69229269T DE69229269T2 DE 69229269 T2 DE69229269 T2 DE 69229269T2 DE 69229269 T DE69229269 T DE 69229269T DE 69229269 T DE69229269 T DE 69229269T DE 69229269 T2 DE69229269 T2 DE 69229269T2
Authority
DE
Germany
Prior art keywords
amino acids
pro
asp
arg
gln
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69229269T
Other languages
German (de)
English (en)
Other versions
DE69229269D1 (de
Inventor
Fernando Alvarez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of DE69229269D1 publication Critical patent/DE69229269D1/de
Application granted granted Critical
Publication of DE69229269T2 publication Critical patent/DE69229269T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69229269T 1991-06-17 1992-06-16 Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik Expired - Fee Related DE69229269T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9107363A FR2677653A1 (fr) 1991-06-17 1991-06-17 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune.
PCT/FR1992/000539 WO1992022656A1 (fr) 1991-06-17 1992-06-16 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune

Publications (2)

Publication Number Publication Date
DE69229269D1 DE69229269D1 (de) 1999-07-01
DE69229269T2 true DE69229269T2 (de) 1999-11-11

Family

ID=9413909

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229269T Expired - Fee Related DE69229269T2 (de) 1991-06-17 1992-06-16 Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik

Country Status (9)

Country Link
US (1) US5830667A (https=)
EP (1) EP0589993B1 (https=)
JP (1) JP3284240B2 (https=)
AT (1) ATE180512T1 (https=)
CA (1) CA2111672A1 (https=)
DE (1) DE69229269T2 (https=)
ES (1) ES2133320T3 (https=)
FR (1) FR2677653A1 (https=)
WO (1) WO1992022656A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2313377B (en) * 1996-05-20 1998-07-01 Sumitomo Chemical Co Kit for diagnosis of hepatitis C and alcoholic cirrhosis
DE19805815C1 (de) 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
DE19930933B4 (de) * 1998-07-10 2005-05-25 Imtec Immundiagnostika Gmbh Verfahren zur Bestimmung von anti-LKM 1-Antikörpern
US6787303B1 (en) 1999-04-01 2004-09-07 Alton Ochsner Medical Foundation Identification of a novel retrovirus associated with primary sclerosing cholangitis and autoimmune hepatitis
US7015008B2 (en) * 2000-09-29 2006-03-21 Merck & Co., Inc. Antibodies for human cytochrome P450 2D6
US20040096874A1 (en) * 2002-04-11 2004-05-20 Third Wave Technologies, Inc. Characterization of CYP 2D6 genotypes
JP2012533521A (ja) * 2008-07-17 2012-12-27 ニュートリペップ・ピーティーワイ・リミテッド 治療剤
CN102955027A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体抗lc-1抗体的试剂盒及其检测方法
CN102707055A (zh) * 2012-06-11 2012-10-03 郑州安图绿科生物工程有限公司 一种联合或单独检测自身免疫性肝病相关抗体的试剂盒及其检测方法
CN102955030A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体ana的试剂盒及其检测方法
CN102955026A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体asma的试剂盒及其检测方法
GB201507719D0 (en) * 2015-05-06 2015-06-17 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
IL308202A (en) 2015-05-06 2024-01-01 Immatics Biotechnologies Gmbh Novel peptides and combination of oeptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
EP3477303A1 (en) * 2017-10-27 2019-05-01 Medizinische Hochschule Hannover Method and means for diagnosing autoimmune hepatitis using autoantibody markers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV

Also Published As

Publication number Publication date
WO1992022656A1 (fr) 1992-12-23
US5830667A (en) 1998-11-03
EP0589993A1 (fr) 1994-04-06
CA2111672A1 (en) 1992-12-23
FR2677653A1 (fr) 1992-12-18
ATE180512T1 (de) 1999-06-15
DE69229269D1 (de) 1999-07-01
JPH06510663A (ja) 1994-12-01
JP3284240B2 (ja) 2002-05-20
FR2677653B1 (https=) 1995-04-14
EP0589993B1 (fr) 1999-05-26
ES2133320T3 (es) 1999-09-16

Similar Documents

Publication Publication Date Title
DE69628336T2 (de) Behandlung und diagnose helicobacter pylori infektionen
DE69229269T2 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
Franklin et al. Structural units of human 7S gamma globulin
DE3751310T2 (de) Peptide zur Diagnose von HTLV-III-Antikörpern, deren Herstellung und Verwendung.
DE69420556T2 (de) Assay für troponin i aus dem herzmuskel
DE68918497T2 (de) Monoklonale Mäuseantikörper gegen HIV-IP24 und ihre Verwendung in Diagnostika.
DE68916421T2 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
DE3781078T2 (de) Verwendunng eines peptids zur herstellung von zusammensetzungen fuer die linderung, behandlung und diagnose von autoimmunkrankheiten, insbesondere arthritis, zu diesem peptid analoge verbindungen, mikro-organismen, die dieses peptid oder eine zu diesem peptid analoge verbindung produzieren, als auch pharmazeutische und diagnostische zusammensetzungen und test kits.
DE68925935T2 (de) Antikörper gegen Interleukin-1-beta
DE69737870T2 (de) Medikamente für die diagnostik von autoimmunerkrankungen
Langeland A Clinical and Immunological Study of Allergy to Hen's Egg White: II, Antigens in Hen's Egg White Studied by Crossed Immunoelectrophoresis (CIE)
DE69619405T2 (de) Verbindungen und verfahren zum nachweis und zur vorbeugung von t.cruzi infektionen
DE3218312A1 (de) Monoklonale antikoerper, hybridoma-zellklone, verfahren zu ihrer herstellung und ihre verwendung zur erkennung von brustkrebs und maligner lymphogranulomatose
US5047509A (en) Abnormally glycosylated variants of a2 macroglobulin
US5616685A (en) snRNP-A antigen and fragments thereof
DE68927635T2 (de) Igm-antikörper gegen protamin
DE68921360T2 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus.
DE69733957T2 (de) Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta
EP0676965B1 (en) Method of reducing immunogenicity of variable region of antibodies
Abrass Evaluation of sequential glomerular eluates from rats with Heymann nephritis.
DE3855280T2 (de) Von mca 16-88 erkanntes antigen
DE60014616T2 (de) Antikörper gegen plazentaprotein 13
DE69433787T2 (de) HTLV-I UND HTLV-II gp21 abgeleitete Peptide zur diagnostischen Verwendung
Connor et al. Incidence and reactivity patterns of skeletal and heart (SH) reactive autoantibodies in the sera of patients with myasthenia gravis
Renier et al. Golgi autoantibodies and autoantigens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee